Medtronic Plc (MDT) J.P. Morgan 41st Annual Healthcare Conference

Medtronic plc (NYSE:MDT) J.P. Morgan 41st Annual Healthcare Conference January 9, 2023 11:15 AM ET

Company Participants

Geoff Martha - Chairman and Chief Executive Officer
Karen Parkhill - Chief Financial Officer
Que Dallara - Executive Vice President and President, Diabetes Operating Unit
Sean Salmon - Executive Vice President and President, Cardiovascular Portfolio

Conference Call Participants

Robbie Marcus - J.P. Morgan

Operator

Thanks, everyone. We'll get started here. I'm Robbie Marcus, the medtech analyst at J.P. Morgan. I'm very happy to have Medtronic as our next company here. I'm going to call up Geoff Martha, Chairman and CEO, and then we'll do a little Q&A after. Geoff?

Geoff Martha

All right. Thanks, Robbie. Okay. Thanks for the introduction, Robbie. And thanks to all of you for joining the Medtronic presentation this morning and what looks like to be a packed house. And despite the rain or at least the threat of rain, it wasn't nearly as bad as we were told. It's great to be back in-person here in San Francisco.

And before I get started, I do want to remind you of some disclosures, including that I'll be making some forward-looking statements today that may -- and may reference some non-GAAP financial measures. And I encourage you to read these disclosures, which are also available on our Investor Relations website as part of this presentation.

Okay. So let's get going here. So today I want to update you on the steps that we're taking to set up Medtronic for durable growth. While it hasn't yet translated into our financial results, we have an aggressive transformation underway in the company and I'll share with you today how the actions that we're taking get at the root causes of what's held Medtronic back. And cover some of the proof points that these changes are working. I'll talk about